Hemispherx Ending Licensing Deal in Spain, Portugal and Andorra

Hemispherx Biopharma Inc. said Monday it plans to terminate a license agreement that gives Laboratorios Del Dr. Esteve the right to market Ampligen for chronic fatigue syndrome in Spain, Portugal and Andorra.
Philadelphia Business Journal